Takeda Pharmaceuticals

Takeda Pharmaceuticals, Scripps Research Institute Expand Collaboration

The partnership is intended to identify potential new drugs and compounds for various diseases.

The Scripps Research Institute (TSRI) and the Takeda Pharmaceutical Company have announced plans to expand their recent research collaboration to search for new drug targets for a variety of diseases.

The new agreement extends an initial collaboration launched in 2010 between scientists on the Florida campus of TSRI and Envoy Therapeutics that led to several breakthroughs in identifying potential new compounds for neurological and psychiatric diseases. Envoy was acquired by Takeda Pharmaceuticals last November.

No votes yet
Syndicate content